Pfizer Inc. v. Mylan Laboratories, Inc. , 236 F. App'x 608 ( 2007 )


Menu:
  •                          NOTE: This order is nonprecedential.
    United States Court of Appeals for the Federal Circuit
    2007-1194
    PFIZER INC.,
    Plaintiff-Appellee,
    v.
    MYLAN LABORATORIES, INC. and MYLAN PHARMACEUTICALS, INC.,
    Defendants-Appellants.
    ON MOTION
    Before SCHALL, GAJARSA, and LINN, Circuit Judges.
    LINN, Circuit Judge.
    ORDER
    Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. (Mylan) move for
    summary reversal of the judgment and amended judgment of the United States District
    Court for the Western District of Pennsylvania. Pfizer Inc. opposes.
    On March 22, 2007, in Pfizer, Inc. v. Apotex, Inc., 
    480 F.3d 1348
     (Fed. Cir.
    2007), this court held that the asserted claims of Pfizer's patent are invalid. On May 21,
    2007, this court denied Pfizer's petition for rehearing en banc in that case and the
    mandate issued.
    Upon consideration thereof,
    IT IS ORDERED THAT:
    (1)    Mylan's motion for summary reversal is granted.           The district court's
    judgment and amended judgment are reversed.
    (2)   Each side shall bear its own costs.
    FOR THE COURT
    June 5, 2007                             /s/ Richard Linn
    Date                                  Richard Linn
    Circuit Judge
    cc:   Richard G. Greco, Esq.
    David J. Harth, Esq.
    s8
    ISSUED AS A MANDATE:            June 5, 2007
    2007-1194                               -2-
    

Document Info

Docket Number: 2007-1194

Citation Numbers: 236 F. App'x 608

Judges: Gajarsa, Linn, Schall

Filed Date: 6/8/2007

Precedential Status: Non-Precedential

Modified Date: 8/3/2023